Apellis Pharmaceuticals to Present at the Bank of America Securities 2023 Healthcare Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Apellis Pharmaceuticals to Present at the Bank of America Securities 2023 Healthcare Conference

Citi Comments on Apellis Pharmaceuticals (APLS), Moves PT to $106

May 5, 2023 11:15 AM EDT

Citi analyst Yigal Nochomovitz raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $106.00 (from $88.00) while maintaining a Buy rating.

The analyst comments "The first quarter of any drug launch is frequently a wildcard. Syfovre embodied this uncertainty given 1) mid-1Q23 approval, 2) temporary J-code,... More